Cargando…

Psychosis in behavioral variant frontotemporal dementia

BACKGROUND: Dementia is generally characterized by cognitive impairment that can be accompanied by psychotic symptoms; for example, visual hallucinations are a core feature of dementia with Lewy bodies, and delusions are often seen in Alzheimer’s disease. However, for behavioral variant of frontotem...

Descripción completa

Detalles Bibliográficos
Autores principales: Gossink, Flora T, Vijverberg, Everard GB, Krudop, Welmoed, Scheltens, Philip, Stek, Max L, Pijnenburg, Yolande AL, Dols, Annemiek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402723/
https://www.ncbi.nlm.nih.gov/pubmed/28458550
http://dx.doi.org/10.2147/NDT.S127863
_version_ 1783231284222361600
author Gossink, Flora T
Vijverberg, Everard GB
Krudop, Welmoed
Scheltens, Philip
Stek, Max L
Pijnenburg, Yolande AL
Dols, Annemiek
author_facet Gossink, Flora T
Vijverberg, Everard GB
Krudop, Welmoed
Scheltens, Philip
Stek, Max L
Pijnenburg, Yolande AL
Dols, Annemiek
author_sort Gossink, Flora T
collection PubMed
description BACKGROUND: Dementia is generally characterized by cognitive impairment that can be accompanied by psychotic symptoms; for example, visual hallucinations are a core feature of dementia with Lewy bodies, and delusions are often seen in Alzheimer’s disease. However, for behavioral variant of frontotemporal dementia (bvFTD), studies on the broad spectrum of psychotic symptoms are still lacking. The aim of this study was to systematically and prospectively subtype the wide spectrum of psychotic symptoms in probable and definite bvFTD. METHODS: In this study, a commonly used and validated clinical scale that quantifies the broad spectrum of psychotic symptoms (Positive and Negative Symptom Scale) was used in patients with probable and definite bvFTD (n=22) and with a primary psychiatric disorder (n=35) in a late-onset frontal lobe cohort. Median symptom duration was 2.8 years, and the patients were prospectively followed for 2 years. RESULTS: In total, 22.7% of bvFTD patients suffered from delusions, hallucinatory behavior, and suspiciousness, although the majority of the patients exhibited negative psychotic symptoms such as social and emotional withdrawal and blunted affect (95.5%) and formal thought disorders (81.8%). “Difficulty in abstract thinking” and “stereotypical thinking” (formal thought disorders) differentiated bvFTD from psychiatric disorders. The combined predictors difficulty in abstract thinking, stereotypical thinking, “anxiety”, “guilt feelings,” and “tension” explained 75.4% of variance in the diagnosis of bvFTD versus psychiatric diagnoses (P<0.001). CONCLUSION: Delusions, hallucinatory behavior, and suspiciousness were present in one-fifth of bvFTD patients, whereas negative psychotic symptoms such as social and emotional withdrawal, blunted affect, and formal thought disorders were more frequently present. This suggests that negative psychotic symptoms and formal thought disorders have an important role in the psychiatric misdiagnosis in bvFTD; misdiagnosis in bvFTD might be reduced by systematically exploring the broad spectrum of psychiatric symptoms.
format Online
Article
Text
id pubmed-5402723
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54027232017-04-28 Psychosis in behavioral variant frontotemporal dementia Gossink, Flora T Vijverberg, Everard GB Krudop, Welmoed Scheltens, Philip Stek, Max L Pijnenburg, Yolande AL Dols, Annemiek Neuropsychiatr Dis Treat Original Research BACKGROUND: Dementia is generally characterized by cognitive impairment that can be accompanied by psychotic symptoms; for example, visual hallucinations are a core feature of dementia with Lewy bodies, and delusions are often seen in Alzheimer’s disease. However, for behavioral variant of frontotemporal dementia (bvFTD), studies on the broad spectrum of psychotic symptoms are still lacking. The aim of this study was to systematically and prospectively subtype the wide spectrum of psychotic symptoms in probable and definite bvFTD. METHODS: In this study, a commonly used and validated clinical scale that quantifies the broad spectrum of psychotic symptoms (Positive and Negative Symptom Scale) was used in patients with probable and definite bvFTD (n=22) and with a primary psychiatric disorder (n=35) in a late-onset frontal lobe cohort. Median symptom duration was 2.8 years, and the patients were prospectively followed for 2 years. RESULTS: In total, 22.7% of bvFTD patients suffered from delusions, hallucinatory behavior, and suspiciousness, although the majority of the patients exhibited negative psychotic symptoms such as social and emotional withdrawal and blunted affect (95.5%) and formal thought disorders (81.8%). “Difficulty in abstract thinking” and “stereotypical thinking” (formal thought disorders) differentiated bvFTD from psychiatric disorders. The combined predictors difficulty in abstract thinking, stereotypical thinking, “anxiety”, “guilt feelings,” and “tension” explained 75.4% of variance in the diagnosis of bvFTD versus psychiatric diagnoses (P<0.001). CONCLUSION: Delusions, hallucinatory behavior, and suspiciousness were present in one-fifth of bvFTD patients, whereas negative psychotic symptoms such as social and emotional withdrawal, blunted affect, and formal thought disorders were more frequently present. This suggests that negative psychotic symptoms and formal thought disorders have an important role in the psychiatric misdiagnosis in bvFTD; misdiagnosis in bvFTD might be reduced by systematically exploring the broad spectrum of psychiatric symptoms. Dove Medical Press 2017-04-13 /pmc/articles/PMC5402723/ /pubmed/28458550 http://dx.doi.org/10.2147/NDT.S127863 Text en © 2017 Gossink et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Gossink, Flora T
Vijverberg, Everard GB
Krudop, Welmoed
Scheltens, Philip
Stek, Max L
Pijnenburg, Yolande AL
Dols, Annemiek
Psychosis in behavioral variant frontotemporal dementia
title Psychosis in behavioral variant frontotemporal dementia
title_full Psychosis in behavioral variant frontotemporal dementia
title_fullStr Psychosis in behavioral variant frontotemporal dementia
title_full_unstemmed Psychosis in behavioral variant frontotemporal dementia
title_short Psychosis in behavioral variant frontotemporal dementia
title_sort psychosis in behavioral variant frontotemporal dementia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402723/
https://www.ncbi.nlm.nih.gov/pubmed/28458550
http://dx.doi.org/10.2147/NDT.S127863
work_keys_str_mv AT gossinkflorat psychosisinbehavioralvariantfrontotemporaldementia
AT vijverbergeverardgb psychosisinbehavioralvariantfrontotemporaldementia
AT krudopwelmoed psychosisinbehavioralvariantfrontotemporaldementia
AT scheltensphilip psychosisinbehavioralvariantfrontotemporaldementia
AT stekmaxl psychosisinbehavioralvariantfrontotemporaldementia
AT pijnenburgyolandeal psychosisinbehavioralvariantfrontotemporaldementia
AT dolsannemiek psychosisinbehavioralvariantfrontotemporaldementia